BPC-157 vs CJC-1295 vs TB-500

A three-way comparison to help you find the right peptide for your research goals.

BPC-157

Body Protection Compound-157 is a synthetic peptide derived from a protein found in human gastric juice. It has shown remarkable healing properties in research studies.

Full details →

CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone.

Full details →

TB-500

Thymosin Beta-4 (TB-500) is a naturally occurring peptide present in almost all human and animal cells. It plays a crucial role in tissue repair and regeneration.

Full details →

Side-by-Side Comparison

Aspect	BPC-157	CJC-1295	TB-500
Dose Range	250 mcg–500 mcg	1 mg–2 mg	2 mg–2.5 mg
Frequency	2x daily	Less than daily	Less than daily
Cycle Length	4–6 weeks	8–12 weeks	4–8 weeks
Route	subcutaneous	subcutaneous	subcutaneous
Mechanism	BPC-157 works through multiple pathways including upregulation of growth factor expression, nitric oxide system modulation, and promotion of angiogenesis. It enhances tendon-to-bone healing and supports the formation of new blood vessels.	CJC-1295 binds to GHRH receptors in the pituitary, triggering increased production and release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life significantly.	TB-500 promotes cell migration and differentiation, regulates actin (a cell-building protein), and reduces inflammation. It supports the formation of new blood vessels and wound healing.
Typical Dosage	Typical research dosages range from 250-500mcg administered 1-2 times daily. Both subcutaneous and oral administration have been studied.	CJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.	Research protocols typically use 2-2.5mg twice weekly during the loading phase, followed by maintenance dosing of 2mg every 2 weeks.
Administration	Can be administered subcutaneously near the injury site or systemically. Stable in gastric juice, making oral administration viable.	Subcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.	Administered via subcutaneous or intramuscular injection. Some protocols suggest injection near injury sites.
Side Effects	Generally well-tolerated in research. Some reports of mild nausea or dizziness at higher doses.	Water retention, tingling in extremities, potential increase in cortisol and prolactin levels.	May cause temporary fatigue, headache, or localized irritation at injection sites.
Best For	Muscle Growth Recovery & Healing	Muscle Growth Fat Loss Sleep Quality	Muscle Growth Recovery & Healing